Montelukast potentiates the protective effect of rofecoxib against kainic acid-induced cognitive dysfunction in rats

Pharmacology Biochemistry and Behavior

Volumn 103, Issue 1, 2012, Pages 43-52

  Kumar, Anil ^a   Prakash, Atish ^a   Pahwa, Deeksha ^a   Mishra, Jitendriya ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Kainic acid; Mild cognitive impairment; Montelukast; Neuroinflammation; Rofecoxib

Indexed keywords

ACETYLCHOLINESTERASE; CAFFEIC ACID; GLUTATHIONE; KAINIC ACID; LIPOXYGENASE; MONTELUKAST; PROSTAGLANDIN SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); ROFECOXIB; SUCCINATE DEHYDROGENASE (UBIQUINONE); TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CELL DENSITY; CELL FUNCTION; CEREBROSPINAL FLUID; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME ACTIVITY; ENZYME INHIBITION; HISTOPATHOLOGY; LATENT PERIOD; LOCOMOTION; LOW DRUG DOSE; MEMORY; MILD COGNITIVE IMPAIRMENT; MITOCHONDRION; NERVOUS SYSTEM INFLAMMATION; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ACETATES; ACETYLCHOLINESTERASE; ANIMALS; ANTIOXIDANTS; CAFFEIC ACIDS; COGNITION DISORDERS; CYCLOOXYGENASE 2 INHIBITORS; DRUG SYNERGISM; GLUTATHIONE; HIPPOCAMPUS; KAINIC ACID; LACTONES; LEUKOTRIENE ANTAGONISTS; LIPOXYGENASE INHIBITORS; MAZE LEARNING; MEMORY; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; NEUROTOXINS; OXIDATION-REDUCTION; OXIDATIVE STRESS; QUINOLINES; RATS; RATS, WISTAR; SULFONES; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; RATTUS;

EID: 84865312856     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2012.07.015     Document Type: Article

References (61)

1. M. Bach, X. Norel, L. Walch, J. Gascard, V. de Montpreville, and S. Dahlén Prostacyclin modulation of contractions of the human pulmonary artery by cysteinyl-leukotrienes Eur J Pharmacol 401 2000 389 395
2. M.K. Baskaya, Y. Hu, D. Donaldson, M. Maley, A.M. Rao, and M.R. Prasad Protective effect of the 5-lipoxygenase inhibitor AA-861 on cerebral edema after transient ischemia J Neurosurg 85 1996 112 116
3. F. Benetti, P.B. Mello, J.S. Bonini, S. Monteiro, M. Cammarota, and I. Izquierdo Early postnatal maternal deprivation in rats induces memory deficits in adult life that can be reversed by donepezil and galantamine Int J Dev Neurosci 27 2009 59 64
4. S.B. Berman, and T.G. Hastings Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease J Neurochem 73 1999 1127 1137
5. P. Bezzi, G. Carmignoto, L. Pasti, S. Vesce, D. Rossi, and B.L. Rizzini Prostaglandins stimulate calcium-dependent glutamate release in astrocytes Nature 391 1998 281 285
6. K.L. Black, J.T. Hoff, J.E. McGillicuddy, and S.S. Gebarski Increased leukotriene C4 and vasogenic edema surrounding brain tumors in humans Ann Neurol 19 1986 592 595
7. C. Brink, S.E. Dahlen, J. Drazen, J.F. Evans, D.W. Hay, and S. Nicosia International union of pharmacology XXXVII: nomenclature for leukotriene and lipoxin receptors Pharmacol Rev 55 2003 195 227
8. L.-S. Chu, E.-Q. Wei, G.-L. Yu, S.-H. Fang, Y. Zhou, and M. Wang Pranlukast reduces neutrophil but not macrophage/microglial accumulation in brain after focal cerebral ischemia in mice Acta Pharmacol Sin 27 2006 282 288
9. R. Ciccarelli, I. D'Alimonte, C. Santavenere, M. D'Auro, P. Ballerini, and E. Nargi Cysteinyl-leukotrienes are released from astrocytes and increase astrocyte proliferation and glial fibrillary acidic protein via Cys-LT1 receptors and mitogen-activated protein kinase pathway Eur J Neurosci 20 2004 1514 1524
10. P. Ciceri, M. Rabuffetti, A. Monopoli, and S. Nicosia Production of leukotrienes in a model of focal cerebral ischaemia in the rat Br J Pharmacol 133 2001 1323 1329
11. A.C. Cuello, L. Garofalo, and D. Maysinger Evidence for nerve growth factor-ganglioside interaction in forebrain cholinergic neurons Acta Neurobiol Exp 50 1990 451 460
12. G. Daglar, T. Karaca, Y.N. Yuksek, U. Gozalan, F. Akbiyik, and C. Sokmensuer Effect of montelukast and MK-886 on hepatic ischemia-reperfusion injury in rats J Surg Res 153 2009 31 38
13. S.E. Dahlén The significance of liberated cyclooxygenase products for the pulmonary and cardiovascular actions of leukotriene C4 in the guinea pig depends upon the route of administration Acta Physiol Scand 118 1983 415 421
14. H.S. Dhillon, J.M. Dose, and M.R. Prasad Regional generation of leukotriene C4 after experimental brain injury in anesthetized rats J Neurotrauma 13 1996 781 789
15. Q. Ding, E. Wei, Y. Zhang, W. Zhang, and Z. Chen Cysteinyl leukotriene receptor 1 is involved in N-methyl-d-aspartate-mediated neuronal injury in mice Acta Pharmacol Sin 27 2006 1526 1536
16. P.J. Elliott, L. Garofalo, and A.C. Cuello Limited neocortical devascularizing lesions causing deficits in memory retention and choline acetyltransferase activity-effects of the monosialoganglioside GM1 Neuroscience 31 1989 63 76
17. G.L. Ellman Tissue sulfhydryl groups Arch Biochem Biophys 82 1959 70 77
18. G.L. Ellman, K.D. Courtney, V. Andres Jr., and R.M. Featherstone A new and rapid colorimetric determination of acetylcholinesterase activity Biochem Pharmacol 7 1961 88 90
19. S.H. Fang, E.Q. Wei, Y. Zhou, M.L. Wang, W.P. Zhang, and G.L. Yu Increased expression of cysteinyl leukotriene receptor-1 in the brain mediates neuronal damage and astrogliosis after focal cerebral ischemia in rats Neuroscience 140 2006 969 979
20. J. Finsterer Cognitive decline as a manifestation of mitochondrial disorders (mitochondrial dementia) J Neurol Sci 272 2008 20 33
21. V. Gaur, and A. Kumar Effect of nonselective and selective COX-2 inhibitors on memory dysfunction, glutathione system, and tumor necrosis factor alpha level against cerebral ischemia reperfusion injury Drug Chem Toxicol 35 2 2012 218 224
22. T. Genovese, A. Rossi, E. Mazzon, R. Di Paola, C. Muià, and R. Caminiti Effects of zileuton and montelukast in mouse experimental spinal cord injury Br J Pharmacol 153 2008 568 582
23. A.G. Gornall, C.J. Bardawill, and M.M. David Determination of serum proteins by means of the biuret reaction J Biol Chem 177 1949 751 766
24. L.C. Green, D.A. Wagner, and J. Glagowski Analysis of nitrate nitrite and (15N) nitrate in biological fluids Anal Biochem 126 1982 131 138
25. S.W. Hoffman, and D.G. Stein Extract of Ginkgo biloba (EGb 761) improves behavioral performance and reduces histopathology after cortical contusion in the rat Restor Neurol Neurosci 11 1997 1 12
26. H. Kalonia, P. Kumar, A. Kumar, and B. Nehru Effects of caffeic acid, rofecoxib, and their combination against quinolinic acid-induced behavioral alterations and disruption in glutathione redox status Neurosci Bull 25 2009 343 352
27. H. Kalonia, P. Kumar, A. Kumar, and B. Nehru Protective effect of montelukast against Quinolinic acid/malonic acid induced neurotoxicity: possible behavioral, biochemical, mitochondrial and tumor necrosis factor-α level alterations in rats Neuroscience 171 2010 284 299
28. Kalonia H, Mishra J, Kumar A. Targeting neuro-inflammatory cytokines and oxidative stress by minocycline attenuates quinolinic-acid-induced Huntington's disease-like symptoms in rats. Neurotox Res in press. http://dx.doi.org/10.1007/ s12640-012-9315-x [Electronic publication ahead of print].
29. T.E. King Preparation of succinate dehydrogenase and reconstitution of succinate oxidase Methods Enzymol 10 1967 322 331
30. T.E. King, and R.L. Howard Preparations and properties of soluble NADH dehydrogenases from cardiac muscle Methods Enzymol 10 1967 275 294
31. Y. Kono Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase Arch Biochem Biophys 186 1978 189 195
32. M.H.V. Kumar, and Y.K. Gupta Intracerebroventricular administration of colchicine produces cognitive impairment associated with oxidative stress in rats Pharmacol Biochem Behav 73 2002 565 571
33. A. Kumar, R. Garg, V. Gaur, and P. Kumar Venlafaxine involves nitric oxide modulatory mechanism in experimental model of chronic behavior despair in mice Brain Res 1311 2010 73 80
34. A. Kumar, A. Vashist, and P. Kumar Potential role of pioglitazone, caffeic acid and their combination against fatigue syndrome-induced behavioural, biochemical and mitochondrial alterations in mice Inflammopharmacology 18 5 2010 241 251
35. A. Kumar, A. Prakash, and S. Dogra Centella asiatica attenuates d-Galactose-induced cognitive impairment, oxidative and mitochondrial dysfunction in mice Int J Alzheimers Dis 2011 2011 347569
36. D. Lecca, M.L. Trincavelli, P. Gelosa, L. Sironi, P. Ciana, and M. Fumagalli The recently identified P2Y-like receptor GPR17 is a sensor of brain damage and a new target for brain repair PLoS One 3 2008 e3579
37. Y. Liu, D.A. Peterson, H. Kimura, and D. Schubert Mechanisms of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolinium bromide (MTT) reduction J Neurochem 69 1997 581 593
38. M. Matsuo, Y. Hamasaki, F. Fujiyama, and S. Miyazaki Eicosanoids are produced by microglia not by astrocytes, in rat glial cell cultures Brain Res 685 1995 201 204
39. P. Mecocci, and M.C. Polidori Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease Biochim Biophys Acta 1822 5 2012 631 638
40. R. Morris Developments of a water-maze procedure for studying spatial learning in the rat J Neurosci Methods 11 1984 47 60
41. M.J. O'Neill, T.K. Murray, V. Lakics, N.P. Visanji, and S. Duty The role of neuronal nicotinic acetylcholine receptors in acute and chronic neurodegeneration Curr Drug Targets CNS Neurol Disord 1 2002 399 411
42. G. Paxinos, and C. Watson The rat brain in stereotaxic coordinates 6th edn. 2007 Academic Press San Diego
43. A.M. Rao, J.F. Hatcher, M.S. Kindy, and R.J. Dempsey Arachidonic acid and leukotriene C4: role in transient cerebral ischemia of gerbils Neurochem Res 24 1999 1225 1232
44. R.L. Roof, R. Duvdevani, L. Braswell, and D.G. Stein Progesterone facilitates cognitive recovery and reduces secondary neuronal loss caused by cortical contusion injury in male rats Exp Neurol 129 1994 64 69
45. G. Sener, L. Kabasakal, S. Cetinel, G. Contuk, N. Gedik, and B.C. Yeǧen Leukotriene receptor blocker montelukast protects against burn-induced oxidative injury of the skin and remote organs Burns 31 2005 587 596
46. G. Sener, C. Kapucu, S. Cetinel, E. Cikler, and G. Ayanoǧlu- Dülger Gastroprotective effect of leukotriene receptor blocker montelukast in alendronat-induced lesions of the rat gastric mucosa Prostaglandins Leukot Essent Fatty Acids 72 2005 1 11
47. G. Sener, O. Sehirli, S. Cetinel, F. Ercan, M. Yüksel, and N. Gedik Amelioration of sepsis-induced hepatic and ileal injury in rats by the leukotriene receptor blocker montelukast Prostaglandins Leukot Essent Fatty Acids 73 2005 453 462
48. G. Sener, O. Sehirli, H. Toklu, F. Ercan, and I. Alican Montelukast reduces ischaemia/reperfusion-induced bladder dysfunction and oxidant damage in the rat J Pharm Pharmacol 59 2007 837 842
49. T. Simmet, and B. Tippler Cysteinyl-leukotriene production during limbic seizures triggered by kainic acid Brain Res 515 1990 79 86
50. N. Srivastava, K. Seth, N. Srivastava, V.K. Khanna, and A.K. Agrawal Functional restoration using basic fibroblast growth factor (bFGF) infusion in kainic acid induced cognitive dysfunction in rat: neurobehavioural and neurochemical studies Neurochem Res 33 2008 1169 1177
51. H. Tuǧtepe, G. Sener, S. Cetinel, A. Velioǧlu- Oǧünç, and B.C. Yeǧen Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist Eur J Pharmacol 557 2007 69 75
52. Q. Wang, S. Yu, A. Simonyi, G.Y. Sun, and A.Y. Sun Kainic acid-mediated excitotoxicity as a model for neurodegeneration Mol Neurobiol 31 2005 3 16
53. M.L. Wang, X.J. Huang, S.H. Fang, Y.M. Yuan, W.P. Zhang, and Y.B. Lu Leukotriene D4 induces brain edema and enhances CysLT2 receptor-mediated aquaporin 4 expression Biochem Biophys Res Commun 350 2006 399 404
54. E.D. Wills Mechanism of lipid peroxide formation in animal tissues Biochem J 99 1966 667 676
55. G.L. Yu, E.Q. Wei, S.H. Zhang, H.M. Xu, L.S. Chu, and W.P. Zhang Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice Pharmacology 73 2005 31 40
56. G.L. Yu, E.Q. Wei, M.L. Wang, W.P. Zhang, S.H. Zhang, and J.Q. Weng Pranlukast, a cysteinyl leukotriene receptor-1 antagonist, protects against chronic ischemic brain injury and inhibits the glial scar formation in mice Brain Res 1053 2005 116 125
57. Y.-M. Yuan, S.-H. Fang, X.-D. Qian, L.-Y. Liu, L.-H. Xu, and W.-Z. Shi Leukotriene D4 stimulates the migration but not proliferation of endothelial cells mediated by the cysteinyl leukotriene CysLT1 receptor via the extracellular signal-regulated kinase pathway J Pharmacol Sci 109 2009 285 292
58. W.L. Zahler, and W.W. Cleland A specific and sensitive assay for disulfides J Biol Chem 243 1968 716 719
59. E.R. Zanier, S.M. Lee, P.M. Vespa, C.C. Giza, and D.A. Hovda Increased hippocampal CA3 vulnerability to low-level kainic acid following lateral fluid percussion injury J Neurotrauma 20 2003 409 420
60. L.H. Zhang, and E.Q. Wei Neuroprotective effect of ONO-1078, a leukotriene receptor antagonist, on transient global cerebral ischemia in rats Acta Pharmacol Sin 24 2003 1241 1247
61. L. Zhang, F.M. Zhou, and J.A. Dani Cholinergic drugs for Alzheimer's disease enhance in vitro dopamine release Mol Pharmacol 66 2004 538 544